Patent · US Active

Heterocyclic amide derivatives as P2X7 receptor antagonists

US9388197B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Kurt Hilpert · Therwil, CH
Francis Hubler
Dorte Renneberg · Allschwil, CH
Simon Stamm · Allschwil, CH

Key dates

Filing date	Jan 21, 2014
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Jan 21, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D277/82
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to heterocyclic amide derivatives of formula (I),wherein R1, R2, R3, R4, R5, n, m, p and X are as defined in the description, their preparation and their use as pharmaceutically active compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.